Microphysiological systems for immuno-oncology: opportunities and challenges

Published: 7 July 2021
Lucie A Low
Lucie A Low
National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Blvd, 9th Floor, Bethesda, MD 20892, USA lucie.low@nih.gov
Lucie Low is the scientific program manager of the trans-NIH Tissue Chip for Drug Screening program at the National Center for Advancing Translational Sciences (NCATS). She also serves as the NIH-NASA liaison point of contact, facilitating collaborations between NIH and NASA on areas of overlapping agency interest. Prior to joining NCATS in 2016, Low was an intramural research fellow at the National Center for Complementary and Integrative Health (NCCIH), researching the complex interactions between pain, emotion and cognition. She obtained her undergraduate degree from Magdalen College, Oxford University, and her Masters and PhD degrees in Neuroscience from University College London in the UK. She undertook postdoctoral training at McGill University in Montreal, Canada, before joining the US National Institutes of Health in 2012. She has authored over 20 peer-reviewed manuscripts on the neuroscience of pain and tissue chips.

“...the promise for using microphysiological systems in immuno-oncology applications remains high, with microphysiological systems a potential tool in an expanding array of tools for the treatment of cancer.”

Read now